Search - tctmd.com

Displaying 841 - 860 of 1097

Sort: Relevancy | Date

News Daily News

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

L.A. McKeown

December 21, 2015

News Daily News

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

L.A. McKeown

December 21, 2015

News Daily News

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

Michael O'Riordan

December 06, 2015

News Daily News

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Michael O'Riordan

December 06, 2015

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Opinion Fellow Talk

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

Waleed Alharbi, MD

November 29, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

November 22, 2015

News Daily News

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

Shelley Wood

November 12, 2015

News Daily News

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

Shelley Wood

November 11, 2015

News Conference News AHA 2015

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

L.A. McKeown

November 08, 2015

Presentation TCT 2015

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Presenter: Steven R. Bailey, Patrick W. Serruys, Kreton Mavromatis

October 15, 2015

News Conference News TCT 2015

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

Todd Neale

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Debate: Yes, Transcatheter MV Replacement Will Become Standard of Care for Secondary MR!

Presenter: Vinod H. Thourani, Brian K. Whisenant, Shmuel Banai

October 14, 2015

Presentation TCT 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR COUNTERPOINT: The COAPT Bar Is Set Too High and Alternative Trial Designs Are Needed!

Presenter: John C Laschinger, Michael J. Mack, Neil E. Moat

October 14, 2015

Presentation TCT 2015

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR POINT: Defending MVARC and COAPT as the Clear Path to Approval

Presenter: John C Laschinger, Michael J. Mack

October 14, 2015

Presentation TCT 2015

The FDA/EFP for New Mitral Valve Replacement Technologies: Lessons Learned, Current Status, and Future Perspectives

Presenter: Andrew Farb, Jason H. Rogers, Changfu Wu

October 14, 2015

News Conference News TCT 2015

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

October 14, 2015

Advertisement

Percutaneous Mitral Repair Looks Durable, Safe, in 5-Year Final Results from EVEREST II

La Reparación Mitral Percutánea parece Duradera y Segura en los Resultados a 5 Años del EVEREST II

EVEREST II 5 年的最终结果显示经皮二尖瓣修补似乎持久、安全

La 1ª Reparación Transcatéter en Humanos de la Válvula Tricúspide es Viable pero Plantea Interrogantes

First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

Ten Essential Adjunctive Skillsets for the Budding Structural Interventionist

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)

Más de 1 de cada 10 Pacientes del Registro norteamericano TAVR Tratados Fuera de indicación

More Than 1 in 10 Patients in US TAVR Registry Treated Off-Label

At 2 Years, Surgical Valve Replacement Still Beats Repair in Severe Mitral Regurgitation

TCT 111: Impact of Concomitant Mitral Regurgitation Following Transcatheter Aortic Valve Replacement Insights From the US TVT National Registry

Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Debate: Yes, Transcatheter MV Replacement Will Become Standard of Care for Secondary MR!

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR COUNTERPOINT: The COAPT Bar Is Set Too High and Alternative Trial Designs Are Needed!

Controversial Viewpoints: Clinical Trial Designs for Transcatheter Repair/Replacement of Functional MR POINT: Defending MVARC and COAPT as the Clear Path to Approval

The FDA/EFP for New Mitral Valve Replacement Technologies: Lessons Learned, Current Status, and Future Perspectives

Percutaneous Paravalvular Leak Closure in Failed Surgical Valves Feasible

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content